Oculis OCS
$7.06 −$0.38 (-5.11%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $7.06 0.00%
Open$7.38
Prev close$7.44
Day range$6.98 – $7.43
Volume235.2K
Market cap$437.15M
P/E (TTM)–
Dividend yield–
OCS Stock News
Headlines matching Oculis or the OCS ticker, most recent first.
- Top-performing Hong Kong stocks this week | Lightelligence shares rose more than 21% for the week, with its Scale-up OCS becoming a core growth engine; the company was included in the Stock Connect program this month. Maifeishi gained nearly 21%, upgradin Positive
- Stifel Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $40
- Dongtu Technology (300353.SZ): The industrial network communications business segment does not involve OCS optical circuit switching products.
- Material Management Information related to Judgment of Investment ([국책과제 선정]피지컬AI 기반 SW플랫폼 연구개발 생태계 조성사업(협업지능 피지컬AI SW 표준화 및 모듈형 SDF-OCS 설계 구축))
- H.C. Wainwright Maintains Oculis(OCS.US) With Buy Rating, Raises Target Price to $39 Positive
- LifeSci Capital Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $41
- Needham Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $38
- LifeSci Capital Maintains Oculis(OCS.US) With Buy Rating, Cuts Target Price to $41 Negative
- Guggenheim Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $45
- LifeSci Capital Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $45
- TransMedics (TMDX): Buy Rating Backed by Accelerating U.S. Organ Transplant Volumes and Expanding OCS Utilization
- H.C. Wainwright Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $26
- J.P. Morgan Maintains Oculis(OCS.US) With Buy Rating, Cuts Target Price to $20 Negative
- J.P. Morgan Gives a Buy Rating to Oculis Holding (OCS)
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Oculis Holding (OCS), Stevanato Group (STVN) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)
No comments yet — be the first to weigh in on OCS.
Sign in to join the discussion.